ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
WuXi Biologics says it will build a $60 million biologics discovery, development, and manufacturing center in Worcester, Massachusetts. WuXi expects the 9,940 m2 facility, its first biologics plant in the US, to open in 2022. The Chinese firm says the plant will have 4,500 L of bioreactor capacity and employ about 150 people. It will run with continuous bioprocessing, deploying single-use reactors for clinical and small-volume commercial production.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X